X-RAY-morphological features of the current COVID-19 and HIV infection
https://doi.org/10.22328/2077-9828-2021-13-2-77-84
Abstract
Infection of HIV-infected with a new coronavirus infection, due to its high contagiousness, is inevitably growing all over the world. According to estimates of Chinese scientists, their number is currently more than 500 thousand people. Considering that COVID-19 leads to suppression of immunity and the emergence of opportunistic infections in HIV-negative patients, the activation of secondary diseases in patients with HIV is natural. In view of this, the study of the features of the X-ray morphological picture of inflammatory changes in the lungs according to MSCT data in patients with COVID-19/HIV became the goal of this study. 13 patients who underwent treatment at the Surgut Regional Clinical Hospital during the period from March to July 2020 underwent MSCT of the chest organs upon admission, before discharge, as well as in case of deterioration or lack of effect from the therapy — every 3 days. The detection of pathognomonic CT signs of COVID-19 in the lungs in patients with HIV (the nature of the lesion, the stage of the disease, the severity of the inflammatory process) was carried out in parallel with the diagnosis of opportunistic infections. During the examination, atypical clinical and X-ray morphological signs of the course of COVID-19/HIV coinfection were identified. In HIV-infected people, COVID-19 proceeds more easily and in disguise, while opportunistic infections both in clinical and radiological manifestations have priority signs. They are the reasons for the aggravation of the course of the disease, as well as the development of complications in these patients.
About the Authors
A. A. Gaus
Surgut State University of the Khanty-Mansiysk Autonomous Okrug — Ugra; Surgut Regional Clinical Hospital
Russian Federation
Russian Federation
Surgut
N. V. Klimova
Surgut State University of the Khanty-Mansiysk Autonomous Okrug — Ugra; Surgut Regional Clinical Hospital
Russian Federation
Russian Federation
Surgut
References
1. Zhu F., Cao Y., Xu S., Zhou M. Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China // J. Med. Virol. 2020. Vol. 92. Р. 529–530.
2. Zhao J., Liao X., Wang H., Wei L., Xing M., Liu L., Zhang Z. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV // Clin. Infect. Dis. 2020. Vol. 71, No. 16. Р. 2233–2235.
3. Rassokhin V.V., Samarina A.V., Belyakov N.A. Epidemiology, clinical picture, diagnosis, assessment of the severity of COVID-19 disease, taking into account concomitant pathology. HIV infection and immunosuppressive disorders, 2020, Vol. 12, No. 2, рр. 7–30 (In Russ.).
4. Blanco J.L., Ambrosioni J., Garcia F., Martínez E., Soriano A., Mallolas J., Miro J. M. COVID-19 in patients with HIV: clinical case series // The Lancet. 2020. Vol. 7, No. 5. Р. 314–316.
5. Enomoto T., Azuma F., Kohno A., Kaneko K., Saito H., Kametaka M., Usuki J., Gemma A., Kudoh S., Nakamura S. Differences in the clinical characteristics of pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection // Respirology. 2010. Vol. 15, No. 1. Р. 126–131.
6. Bagnenko S.F., Rassokhin V.V., Belyakov N.A. Boeva E.V., Yastrebova E.B. Coronavirus infection COVID-19. Treatment and prevention. HIV infection and immunosuppressive disorders, 2020, Vol. 12, No. 2, рр. 31–55 (In Russ.).
7. Xiao C., Li X., Liu S., Sang Y., Gao Shou-Jiang, Gaob F. HIV-1 did not contribute to the 2019-nCoV genome // Emerg Microbes Infect. 2020. Vol. 9, No. 1. Р. 378–381.
8. Vizcarra P., Pérez-Elнas M.J., Quereda C. et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort // Lancet HIV. 2020. Vol. 7, No. 8. Р. 554–564.
9. Shiau S., Krause K.D., Valera P., Swaminathan S., Halkitis P.N. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective // IDS Behav. 2020 Vol. 24, No. 8. Р. 2244–2249.
10. Li X., Jiang L., Lin F., Wang Y., Liu S., An W. Successful recovery of a severe COVID-19 patient with acquired immunodeficiency syndrome // E Clin. Med. 2020. May; 22. Р. 100342.
11. Kanne J, Yandow D, Meyer C. Pneumocystis jiroveci pneumonia: high-resolution CT-findings in patients with and without HIV infection // AJR Am. J. Roentgenol. 2012. Vol. 198, No. 6. Р. 555–561.
12. Interim Guidance for COVID-19 and Persons with HIV Last Updated: April 21, 2020; Last Reviewed: April 21, 2020.
13. Guo W., Weng H.L., Bai H., Liu J., Wei X.N., Zhou K., Sande A. Quick Community Survey on the Impact of COVID-19 Outbreak for the Healthcare of People Living With HIV // Zhonghua Liu Xing Bing Xue Za Zhi. 2020. Vol. 41, No. 5. Р. 663–669.
14. Chen J., Cheng X., Wang R., Zeng X. Computed Tomography Imaging of an HIV-infected Patient With Coronavirus Disease 2019 (COVID-19) // Affiliations expand. doi: 10.1002/jmv.25879.
15. Ayusheeva L.B., Sinitsyn M.V., Demenok I N. The course of a new coronavirus infection in patients with HIV/tuberculosis coinfection. Tuberculosis and socially significant diseases, 2020, No. 2, рр. 3 (In Russ.).
Review
For citations:
Gaus A.A., Klimova N.V. X-RAY-morphological features of the current COVID-19 and HIV infection. HIV Infection and Immunosuppressive Disorders. 2021;13(2):77-84. (In Russ.) https://doi.org/10.22328/2077-9828-2021-13-2-77-84
Views:
658
.png)
Email this article 